Knowledge Center

Article / Jan 01, 2004

Selecting lactose for a capsule-based dry powder inhaler

Authors:
  • Hartwig Steckel
  • Fadi Eskandar
  • Peter Villax
Source:
Pharmaceutical Technology Europe (2004), 16(4), 23

Dry powder inhalers are a well-accepted dosage form for pulmonary drug delivery and a wide variety are either currently available or development. This article examines a premetered, capsule-based multidose inhaler for which different qualities of _-lactose monohydrate were screened.

Also in the Knowledge Center

Related Content

Hovione expands nasal drug delivery capabilities with the development of nasal powder delivery device technology in collaboration with IDC

Press Release / Nov 29, 2023
Article
View

Drug Product Development

Leveraging our expertise particle engineering, Hovione can now develop oral dosage forms and inhaled dosages forms to offer dependable solutions for complex drug products.

Page
Read more

Continuous Tableting for Drug Product

Hovione´s pragmatic approach to bridging science with manufacturing is now being leveraged for continuous tableting and it is the key to ultimately providing high quality medicines and the success of your drug product.

Page
Read more